Study Design and Conduct This is a 30-day, two-arm, randomized, controlled study.
Enrolled participants will be randomly assigned to one of the following study arms:
- Control group: participating pharmacists will dispense boxes of standard insulin pen needles to the patient participants
- mCPN group: participating pharmacists will dispense boxes of montméd Coloured Pen Needles to the patient participants
Study Sites and Participating Pharmacists All pharmacies in Canada that provide services to individuals with diabetes who use injectable insulin therapy will be eligible to participate in this study. All participating pharmacists who will play an active role in participant enrollment and the follow-up visits will be required to complete a participation consent form and 2 surveys. The first (Pre-study survey) should be completed after they have been fully trained on the study protocol and their study obligations, and before commencement of study enrollment. The second (Post-study survey) should be completed after the last patient has completed the 30-day follow-up visit. (Refer to Section 11 for the Study Flow).
Randomization Process Participating pharmacists will dispense one of the two study pen needles according to a computer-generated list that will be provided to the participating pharmacy upon site activation
